The most noteworthy discovery is that we identified five pivotal immune-associated candidate genes (ITGAL, CXCL16, BEX2, SPRY2, and MORF4L2) and developed a nomogram for diagnosing AVC in MS patients. This evidence concerns the gene MORF4L2 and myeloid sarcoma.